CIK 0001595097
- Non-accelerated filer
- Smaller reporting company
Corbus Pharmaceuticals Holdings, Inc.
Sign in to watch- Ticker
- CRBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464348039
- Phone
- +1 617-963-0103
- Business address
- 500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
- Former names
- SAV Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,758,438
- in 2 filings, $16K under 10b5-1 plans
Net −$1,758,438. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-14 | Tepper Mark President and CSO | Exercise or conversion · Option to purchase common stock | −10,000 | 261,600 | ||
| 2018-06-05 | Jenkins John Kenneth Director | Grant or award · Stock Option(right to buy) | +68,000 | 68,000 | ||
| 2018-05-24 | Panayiotopoulos Paris Director | Grant or award · Stock Option(right to buy) | +34,000 | 34,000 | ||
| 2018-05-24 | HOLMER ALAN F Director | Grant or award · Stock Option(right to buy) | +34,000 | 34,000 | ||
| 2018-05-24 | Hochman David P Director | Gift | −220,000 | 0 | ||
| 2018-05-24 | Hochman David P Director | Gift | +110,000 | 120,000 | ||
| 2018-05-24 | Hochman David P Director | Gift | +110,000 | 110,000 | ||
| 2018-05-24 | Hochman David P Director | Grant or award · Stock Option(right to buy) | +34,000 | 34,000 | ||
| 2018-05-24 | CATLIN AVERY W Director | Grant or award · Stock Option(right to buy) | +34,000 | 34,000 | ||
| 2018-05-15 | White Barbara Chief Medical Officer | Purchase | +2,586 | $5.87 | $15K | 179,521 |
| 2018-05-15 | Cohen Yuval Chief Executive Officer | Purchase | +1,725 | $5.85 | $10K | 61,660 |
| 2018-05-15 | Moran Sean F. Chief Financial Officer | Purchase | +4,000 | $5.77 | $23K | 348,010 |
| 2018-05-14 | Hochman David P Director | Purchase | +5,000 | $5.48 | $27K | 5,000 |
| 2018-03-14 | Hochman David P Director | Purchase | +5,000 | $6.67 | $33K | 225,000 |
| 2018-03-14 | White Barbara Chief Medical Officer | Purchase | +2,885 | $6.89 | $20K | 176,935 |
| 2018-03-14 | Cohen Yuval Chief Executive Officer | Purchase | +1,160 | $6.89 | $8K | 59,935 |
| 2018-03-14 | Moran Sean F. Chief Financial Officer | Purchase | +3,100 | $6.60 | $20K | 344,010 |
| 2018-01-04 | Moran Sean F. Chief Financial Officer | Grant or award · Stock Option(right to buy) | +175,000 | 175,000 | ||
| 2018-01-04 | White Barbara Chief Medical Officer | Grant or award · Stock Option(right to buy) | +175,000 | 175,000 | ||
| 2018-01-04 | Tepper Mark President and CSO | Grant or award · Stock Option(right to buy) | +175,000 | 175,000 |
Page 15 of 16 · 320 trades